Security key
03753U106
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS)
CUSIP: 03753U106
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 127,672,507
- Total 13F shares
- 63,890,305
- Share change
- -264,042
- Total reported value
- $3,654,164,157
- Put/Call ratio
- 57%
- Price per share
- $57.20
- Number of holders
- 165
- Value change
- -$7,921,158
- Number of buys
- 80
- Number of sells
- 71
Report period
Q4 2020
Institutions
165
Top holders
10
APLS full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Apellis Pharmaceuticals, Inc. SEC filings
Apellis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03753U106
Recent filing periods:
Top shareholders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.2%
|
10,452,808
|
$315,361,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.7%
|
5,980,261
|
$180,424,000 | — | 30 Sep 2020 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
3.9%
|
5,028,289
|
$151,703,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
4,318,357
|
$130,285,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.3%
|
2,978,400
|
$89,858,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,864,159
|
$86,412,000 | — | 30 Sep 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.2%
|
2,837,786
|
$85,616,000 | — | 30 Sep 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
2,275,000
|
$68,637,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
2,202,258
|
$66,442,000 | — | 30 Sep 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.7%
|
2,145,462
|
$64,728,000 | — | 30 Sep 2020 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.5%
|
1,866,108
|
$56,300,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
1,331,610
|
$40,175,000 | — | 30 Sep 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.9%
|
1,148,865
|
$34,660,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.72%
|
916,703
|
$27,657,000 | — | 30 Sep 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.7%
|
896,551
|
$27,049,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
877,814
|
$26,483,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.64%
|
812,200
|
$24,504,000 | — | 30 Sep 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.57%
|
726,777
|
$21,927,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
706,160
|
$21,306,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.55%
|
703,405
|
$20,322,000 | — | 30 Sep 2020 | |
| NORGES BANK |
13F
|
Company |
0.5%
|
642,791
|
$19,393,000 | — | 30 Sep 2020 | |
| Avidity Partners Management LP |
13F
|
Company |
0.49%
|
623,300
|
$18,805,000 | — | 30 Sep 2020 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.45%
|
570,591
|
$17,215,000 | — | 30 Sep 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.44%
|
557,231
|
$16,812,000 | — | 30 Sep 2020 | |
| venBio Partners LLC |
13F
|
Company |
0.39%
|
501,584
|
$15,133,000 | — | 30 Sep 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.35%
|
446,936
|
$13,484,000 | — | 30 Sep 2020 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.32%
|
405,834
|
$12,244,000 | — | 30 Sep 2020 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.3%
|
388,037
|
$11,707,000 | — | 30 Sep 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.3%
|
385,866
|
$11,642,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
369,428
|
$11,146,000 | — | 30 Sep 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.27%
|
343,320
|
$11,172,000 | — | 30 Sep 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
310,980
|
$9,382,000 | — | 30 Sep 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
272,547
|
$8,223,000 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
0.21%
|
268,134
|
$8,090,000 | — | 30 Sep 2020 | |
| Man Group plc |
13F
|
Company |
0.19%
|
247,886
|
$7,479,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
238,352
|
$7,191,000 | — | 30 Sep 2020 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.18%
|
225,000
|
$6,788,000 | — | 30 Sep 2020 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.17%
|
216,017
|
$6,517,000 | — | 30 Sep 2020 | |
| AXA S.A. |
13F
|
Company |
0.15%
|
189,427
|
$5,715,000 | — | 30 Sep 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.13%
|
167,054
|
$5,040,000 | — | 30 Sep 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
160,818
|
$4,852,000 | — | 30 Sep 2020 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
136,900
|
$4,130,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.11%
|
136,334
|
$4,113,000 | — | 30 Sep 2020 | |
| FIL Ltd |
13F
|
Company |
0.1%
|
129,319
|
$3,901,000 | — | 30 Sep 2020 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.1%
|
124,270
|
$3,749,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.1%
|
123,940
|
$3,740,000 | — | 30 Sep 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.09%
|
120,243
|
$3,628,000 | — | 30 Sep 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.08%
|
105,422
|
$3,181,000 | — | 30 Sep 2020 | |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY |
13F
|
Company |
0.08%
|
97,083
|
$2,928,000 | — | 30 Sep 2020 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.08%
|
96,415
|
$2,909,000 | — | 30 Sep 2020 |
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) as of Q4 2020
As of 31 Dec 2020,
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,890,305 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, HILLHOUSE CAPITAL ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/, JENNISON ASSOCIATES LLC, STATE STREET CORP, FARALLON CAPITAL MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, and Cormorant Asset Management, LP.
This page lists
165
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
143
Q4 2020 holders
165
Holder diff
22
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.